Drugs / AK152
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07301502 Comparator | Dec 2025 → Jun 2027 expected | Alzheimer disease | Akeso | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AK152 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07301502 ↗ |